logo
Home  > Inhibitors/Agonists  > MAPK/ERK Pathway  > MEK  > TAK-733

AE11345

1035555-63-5 | TAK-733

Packsize Purity Availability Price Discounted Price    Quantity
1mg 96% in stock $42.00 $30.00 -   +
2mg 96% in stock $77.00 $54.00 -   +
5mg 96% in stock $130.00 $91.00 -   +
10mg 96% in stock $157.00 $110.00 -   +
25mg 96% in stock $235.00 $165.00 -   +
50mg 96% in stock $401.00 $281.00 -   +
100mg 96% in stock $681.00 $477.00 -   +

*All products are for research use only and not intended for human or animal use.

*All prices are in USD.

Description
Catalog Number: AE11345
Chemical Name: TAK-733
CAS Number: 1035555-63-5
Molecular Formula: C17H15F2IN4O4
Molecular Weight: 504.2267
MDL Number: MFCD24386349
SMILES: OC[C@@H](Cn1cnc2c(c1=O)c(Nc1ccc(cc1F)I)c(c(=O)n2C)F)O

 

Upstream Synthesis Route
  • TAK-733, also known as TAK-632, is a potent and selective inhibitor of the mitogen-activated protein kinase kinase (MEK) enzyme. MEK is a critical component of the MAPK signaling pathway, which regulates cell growth, proliferation, and survival. In chemical synthesis, TAK-733 plays a crucial role as a tool compound for studying the MAPK pathway and its implications in various cellular processes.TAK-733 is commonly used in the research and development of potential cancer therapies due to its ability to inhibit MEK activity, leading to the suppression of downstream signaling pathways involved in tumor progression. By blocking MEK, TAK-733 helps to disrupt abnormal cell growth and promote cancer cell death, making it a valuable asset in the pursuit of novel anti-cancer agents.Furthermore, TAK-733's specificity towards MEK makes it a preferential choice in chemical synthesis aimed at understanding the intricate signaling mechanisms involved in cellular behavior. Its precise targeting of the MAPK pathway allows researchers to investigate the cascades of reactions triggered by MEK inhibition, offering insights into potential therapeutic strategies for various diseases beyond cancer.Through its application in chemical synthesis, TAK-733 serves as a powerful tool for unraveling the complexities of cellular signaling pathways and offers a promising avenue for advancing drug discovery efforts targeted towards MEK-related disorders.
FEATURED PRODUCTS